Michelle Ozaki

1.0k total citations
17 papers, 792 citations indexed

About

Michelle Ozaki is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Michelle Ozaki has authored 17 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Michelle Ozaki's work include Cancer, Hypoxia, and Metabolism (3 papers), Peptidase Inhibition and Analysis (2 papers) and Receptor Mechanisms and Signaling (2 papers). Michelle Ozaki is often cited by papers focused on Cancer, Hypoxia, and Metabolism (3 papers), Peptidase Inhibition and Analysis (2 papers) and Receptor Mechanisms and Signaling (2 papers). Michelle Ozaki collaborates with scholars based in United States, Japan and United Kingdom. Michelle Ozaki's co-authors include Michio Nomura, Charles V. Lowry, Peter Traub, San-ichiro Mizushima, Christina M. Annunziata, Luke C. Davies, Megan Karwan, Jonathan M. Weiss, Robert Y.S. Cheng and Lisa A. Ridnour and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Cancer Research.

In The Last Decade

Michelle Ozaki

17 papers receiving 765 citations

Peers

Michelle Ozaki

ONCOL

IMMUN

GENET

Ernestina Saulle Italy

Reiko Honma Japan

Yu‐Chi Juang United States

Eileen Falvey United States

Evangelia Patsavoudi Greece

Annamaria Bevilacqua Italy

Vanesa G. Martínez Spain

Maria Bonovich United States

Jikhyon Han South Korea

Gilbert Brun France

Ernestina Saulle Italy

Michelle Ozaki

606 ×1.1

108 ×0.6

ONCOL

144 ×0.8

IMMUN

156 ×1.1

75 ×0.9

GENET

Citations per year, relative to Michelle Ozaki Michelle Ozaki (= 1×) peers Ernestina Saulle

Countries citing papers authored by Michelle Ozaki

Since Specialization

Citations

This map shows the geographic impact of Michelle Ozaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Ozaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Ozaki more than expected).

Fields of papers citing papers by Michelle Ozaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Ozaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Ozaki. The network helps show where Michelle Ozaki may publish in the future.

Co-authorship network of co-authors of Michelle Ozaki

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Ozaki. A scholar is included among the top collaborators of Michelle Ozaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Ozaki. Michelle Ozaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Ozaki, Michelle, et al.. (2025). Abstract 6435: Postpartum breast cancer, liver CYP450 metabolism and drug resistance. Cancer Research. 85(8_Supplement_1). 6435–6435. 1 indexed citations

Jindal, Sonali, Nathan D. Pennock, Duanchen Sun, et al.. (2021). Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes. Nature Communications. 12(1). 6341–6341. 21 indexed citations

Harrington, Brittney S., Michelle Ozaki, Lídia Hernandez, et al.. (2020). Drugs Targeting Tumor-Initiating Cells Prolong Survival in a Post-Surgery, Post-Chemotherapy Ovarian Cancer Relapse Model. Cancers. 12(6). 1645–1645. 30 indexed citations

Zeligs, Kristen, Maria Pia Morelli, Justin M. David, et al.. (2020). Evaluation of the Anti-Tumor Activity of the Humanized Monoclonal Antibody NEO-201 in Preclinical Models of Ovarian Cancer. Frontiers in Oncology. 10. 805–805. 8 indexed citations

Weiss, Jonathan M., Luke C. Davies, Megan Karwan, et al.. (2018). Itaconic acid mediates crosstalk between macrophage metabolism and peritoneal tumors. Journal of Clinical Investigation. 128(9). 3794–3805. 190 indexed citations

House, Carrie D., et al.. (2018). IΚΚε cooperates with either MEK or non-canonical NF-kB driving growth of triple-negative breast cancer cells in different contexts. BMC Cancer. 18(1). 595–595. 24 indexed citations

Ozaki, Michelle, Carrie D. House, Krystyna Mazan-Mamczarz, et al.. (2018). Abstract 167: Targeting the NF-kappaB pathway with bardoxolone methyl to inhibit ovarian cancer spheroid formation. Cancer Research. 78(13_Supplement). 167–167. 1 indexed citations

House, Carrie D., et al.. (2018). Abstract 5470: IKK-epsilon supports anchorage independent growth via alternative NF-kB signaling in triple-negative breast cancer. Cancer Research. 78(13_Supplement). 5470–5470. 1 indexed citations

House, Carrie D., Elizabeth Jordan, Lídia Hernandez, et al.. (2017). NFκB Promotes Ovarian Tumorigenesis via Classical Pathways That Support Proliferative Cancer Cells and Alternative Pathways That Support ALDH+ Cancer Stem–like Cells. Cancer Research. 77(24). 6927–6940. 69 indexed citations

10.

Shibuya, Masaaki, Taisuke Kato, Yuichiro Watanabe, et al.. (2010). Measurement and comparison of serum neuregulin 1 immunoreactivity in control subjects and patients with schizophrenia: an influence of its genetic polymorphism. Journal of Neural Transmission. 117(7). 887–895. 45 indexed citations

11.

Kato, Taisuke, Yuichi Abe, Hidekazu Sotoyama, et al.. (2010). Transient exposure of neonatal mice to neuregulin-1 results in hyperdopaminergic states in adulthood: implication in neurodevelopmental hypothesis for schizophrenia. Molecular Psychiatry. 16(3). 307–320. 89 indexed citations

12.

Sakamaki, Kazuhiro, Takayoshi Inoue, Masahide Asano, et al.. (2002). Ex vivo whole-embryo culture of caspase-8-deficient embryos normalize their aberrant phenotypes in the developing neural tube and heart. Cell Death and Differentiation. 9(11). 1196–1206. 101 indexed citations

13.

Ozaki, Michelle, et al.. (1990). CHEMOSENSILLUM OF THE BLOWFLY, PHORMIA REGINA; ISOLATION AND PROTEIN COMPOSITION : Physiology. ZOOLOGICAL SCIENCE. 7(6). 1035. 1 indexed citations

14.

Ochi, T., Koh Yano, Michelle Ozaki, Yujiro Higashi, & Kazuhide Inoue. (1971). Studies on immunity to megacin A: susceptibility of phospholipids to phospholipase A activity of megacin A.. PubMed. 14(1). 29–36. 4 indexed citations

15.

Nomura, Michio, San-ichiro Mizushima, Michelle Ozaki, Peter Traub, & Charles V. Lowry. (1969). Structure and Function of Ribosomes and Their Molecular Components. Cold Spring Harbor Symposia on Quantitative Biology. 34(0). 49–61. 173 indexed citations

16.

Ozaki, Michelle. (1966). Identity of megacin A with phospholipase A. OUKA (Osaka University Knowledge Archive) (Osaka University). 9(3). 201–213. 30 indexed citations

17.

Ozaki, Michelle, et al.. (1963). STUDIES ON THE ROLE OF PLAKIN. X. EFFECT ON MEMBRANE PHOSPHOLIPIDS.. PubMed. 6. 111–26. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact